Key points are not available for this paper at this time.
This study evaluates the cost of routine pretreatment electrocardiogram screening and determines whether testing led to significant management changes for 198 patients evaluated for initiation of treatment with propranolol over a 2-year period.
Streicher et al. (Mon,) studied this question.